Streetbeat News

Earnings

PRCH

Porch Group has projected its FY23 revenue to be around $415 million, which is significantly higher than the estimated $343.62 million.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:08 pm

OLMA

Olema Pharmaceuticals reported Q3 losses of $(0.48) per share, beating the analyst consensus estimate of $(0.51) by 5.88 percent. This represents a 15.79 percent increase over losses from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:08 pm

CRCT

Cricut (NASDAQ:CRCT) reported Q3 earnings of $0.08 per share, beating the analyst consensus estimate of $0.07 by 14.29%. However, the company's quarterly sales of $174.91 million missed the analyst consensus estimate of $196.30 million by 10.90%. This represents a 1.18% decrease over sales of $177.00 million from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:08 pm

IPAR

Inter Parfums reported Q3 earnings per share (EPS) of $1.66, up from $1.30 last year. The company's sales of $367.97M also surpassed the estimate of $362.19M.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:07 pm

WTI

W&T Offshore (NYSE:WTI) reported Q3 earnings of $0.01 per share, missing the analyst consensus estimate of $0.03 by 66.67%. This is a 96.97% decrease from the same period last year. However, the company reported quarterly sales of $142.41 million, beating the analyst consensus estimate of $132.30 million by 7.64%. This is a 46.56% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:07 pm

RXT

Rackspace has projected its Q4 adjusted EPS to be between $(0.05) and $(0.03), which is worse than the estimated $(0.04). The company also expects its total revenue to be between $710M and $720M, lower than the estimated $736.98M.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:07 pm

DNLI

Denali Therapeutics reported Q3 losses of $(0.72) per share, beating the analyst consensus estimate of $(0.82) by 12.2%. This is a 14.29% increase over losses from the same period last year. However, the company's sales decreased by 64.4% YoY to $1.27 million.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:06 pm

POWI

Power Integrations has projected its Q4 2023 revenue to be around $90M, which is significantly lower than the estimated $139.12M.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:06 pm

CRVS

Corvus Pharma reported Q3 losses of $(0.12) per share, which is in line with analyst consensus estimates. This represents a 62.5% improvement over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:06 pm

LUMO

Lumos Pharma reported Q3 losses of $(1.04) per share, beating the analyst consensus estimate of $(1.15) by 9.57%. However, the company's quarterly sales of $7.00K missed the analyst consensus estimate of $320.00K by 97.81%. This represents a 20.93% decrease in losses and a 98.59% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:05 pm